These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 21623040)
1. Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates. Singh M; Jadaun GP; Ramdas ; Srivastava K; Chauhan V; Mishra R; Gupta K; Nair S; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM Indian J Med Res; 2011 May; 133(5):535-40. PubMed ID: 21623040 [TBL] [Abstract][Full Text] [Related]
2. Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype. Sun Z; Xu Y; Sun Y; Liu Y; Zhang X; Huang H; Li C Microb Drug Resist; 2014 Dec; 20(6):525-32. PubMed ID: 24940805 [TBL] [Abstract][Full Text] [Related]
3. A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis. Eilertson B; Maruri F; Blackman A; Guo Y; Herrera M; van der Heijden Y; Shyr Y; Sterling TR J Antimicrob Chemother; 2016 Sep; 71(9):2419-27. PubMed ID: 27261264 [TBL] [Abstract][Full Text] [Related]
4. [Investigation of Efflux Pump Genes in Resistant Mycobacterium tuberculosis Complex Clinical Isolates Exposed to First Line Antituberculosis Drugs and Verapamil Combination]. Özgür D; Ersoy L; Ülger M; Tezcan Ülger S; Aslan G Mikrobiyol Bul; 2023 Apr; 57(2):207-219. PubMed ID: 37067206 [TBL] [Abstract][Full Text] [Related]
5. High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan. Chien JY; Yu CJ; Hsueh PR Int J Antimicrob Agents; 2017 Sep; 50(3):491-495. PubMed ID: 28668684 [TBL] [Abstract][Full Text] [Related]
7. Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux. Louw GE; Warren RM; Gey van Pittius NC; Leon R; Jimenez A; Hernandez-Pando R; McEvoy CR; Grobbelaar M; Murray M; van Helden PD; Victor TC Am J Respir Crit Care Med; 2011 Jul; 184(2):269-76. PubMed ID: 21512166 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin. Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485 [TBL] [Abstract][Full Text] [Related]
9. jefA (Rv2459), a drug efflux gene in Mycobacterium tuberculosis confers resistance to isoniazid & ethambutol. Gupta AK; Reddy VP; Lavania M; Chauhan DS; Venkatesan K; Sharma VD; Tyagi AK; Katoch VM Indian J Med Res; 2010 Aug; 132():176-88. PubMed ID: 20716818 [TBL] [Abstract][Full Text] [Related]
10. Efflux pump effects on levofloxacin resistance in Teng T; Chen S; Huo F; Jia J; Zhao L; Jiang G; Wang F; Chu N; Huang H Antimicrob Agents Chemother; 2024 May; 68(5):e0134823. PubMed ID: 38572960 [No Abstract] [Full Text] [Related]
11. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin]. Yang H; Hu Z; Sha W; Lu J; Cui Z; Wang J; Huang X; Xiao H Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458 [TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Giannoni F; Iona E; Sementilli F; Brunori L; Pardini M; Migliori GB; Orefici G; Fattorini L Antimicrob Agents Chemother; 2005 Jul; 49(7):2928-33. PubMed ID: 15980370 [TBL] [Abstract][Full Text] [Related]
15. Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis. Luo T; Yuan J; Peng X; Yang G; Mi Y; Sun C; Wang C; Zhang C; Bao L J Antimicrob Chemother; 2017 Jul; 72(7):1893-1900. PubMed ID: 28387828 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the Mycobacterium tuberculosis reserpine-sensitive efflux pump augments intracellular concentrations of ciprofloxacin and enhances susceptibility of some clinical isolates. Huang TS; Kunin CM; Wang HM; Yan BS; Huang SP; Chen YS; Lee SS; Syu WJ J Formos Med Assoc; 2013 Dec; 112(12):789-94. PubMed ID: 24331109 [TBL] [Abstract][Full Text] [Related]
17. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels. Chernyaeva E; Fedorova E; Zhemkova G; Korneev Y; Kozlov A Tuberculosis (Edinb); 2013 May; 93(3):291-5. PubMed ID: 23491718 [TBL] [Abstract][Full Text] [Related]
18. Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009. Cui Z; Wang J; Lu J; Huang X; Hu Z BMC Infect Dis; 2011 Mar; 11():78. PubMed ID: 21443804 [TBL] [Abstract][Full Text] [Related]
19. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates. Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489 [TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China. Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]